Copeptin After a Subcutaneous Stimulation With Glucagon in Adults

NACompletedINTERVENTIONAL
Enrollment

42

Participants

Timeline

Start Date

September 28, 2020

Primary Completion Date

May 30, 2021

Study Completion Date

May 30, 2021

Conditions
Diabetes Insipidus
Interventions
DIAGNOSTIC_TEST

Glucagon

Glucagon with the empirical formula of C153H225N43O49S, and a molecular weight of 3483 g/mol, is a single-chain polypeptide containing 29 amino acid residues. Glucagon is provided in a single dose vial as powder. One container contains 1 mg of glucagon which results in a concentration of 1 mg/ml after dissolution in a volume of 1 ml (Glucagen NovoNordisk (Hypokit)). The currently used standard dose regimen is 1 mg of glucagon in adults. The solution for subcutaneous injection will be prepared by the study personnel according to the attached package leaflet.

DIAGNOSTIC_TEST

Placebo

As placebo 1 ml sodium chloride (NaCl) 0.9% to inject subcutaneous is used. It has the same optical appearance as glucagon.

Trial Locations (1)

4031

Divison of Endocrinology, Diabetes and Metabolism,University Hospital Basel, Basel

All Listed Sponsors
collaborator

Swiss National Science Foundation

OTHER

lead

University Hospital, Basel, Switzerland

OTHER

NCT04550520 - Copeptin After a Subcutaneous Stimulation With Glucagon in Adults | Biotech Hunter | Biotech Hunter